Harms From Haloperidol for Symptom Management in Palliative Care —a Post Hoc Pooled Analysis of Three Randomized Controlled Studies and Two Consecutive Cohort Studies

Symptom control for people with cancer improves quality of life. Haloperidol is a key drug in palliative care and is frequently used for the treatment of delirium, nausea, and vomiting.1 Haloperidol, a butyrophenone, is a more potent D2 receptor antagonist than other antiemetics, such as prochlorperazine, olanzapine, or chlorpromazine.

Source: Journal of Pain and Symptom Management - May 19, 2019 Category: Palliative Care Authors: Hiromichi Matsuoka, Meera Agar, Zac Vandersman, Philip Good, Belinda Fazekas, Linda Brown, Hardy Janet, Jennifer Weil, David Christopher Currow Tags: Letter Source Type: research